NIRAF Detection for Thyroid Disease (NIRAF Trial)

"Affirmative. The information available on clinicaltrials.gov confirms that recruitment for this medical trial is ongoing; the initial post was made on March 16th 2020 and it has been updated as recently as April 11th 2022, with a requirement of 160 patients from 1 site."

"The primary assessment of this study will evaluate incidences of postoperative hypoparathyroidism/hypocalcemia within 24 hours after total thyroidectomy. As secondary outcomes, investigators are looking to measure the overall number of parathyroid glands identified via naked eye and near-infrared autofluorescence (NIRAF), auto-transplanted parathyroid glands if accidentally excised or devascularized, and frozen sections sent for analysis during the procedure to confirm potential parathyroid tissue."

"This medical trial welcomes individuals aged 18 and over, up to the age of 99."

"This research project is accepting 160 individuals with thyroid adenoma from 18 to 99 years of age. In particular, the eligibility criteria are as follows: (i) All patients fit for total thyroidectomy (TTx), either with or without lymph node dissection; this includes those who previously had a neck exploration due to parathyroid issues but still have an intact thyroid. and (ii) Everyone undergoing completion thyroidectomy."

"As documented on clinicaltrials.gov, this research initiative is actively recruiting individuals to participate. It was initially posted in March of 2020, with updates done as recently as April 2022."